Medical marijuana
- Medical Review: Brooke Worster, MD, FACP
Cannabis, a plant also known as marijuana, is commonly known for its recreational use. Because of the impact it has on human behavior, its use is federally illegal in the United States. However, many states have adopted legislation enabling what is called medical use or adult use, or both. But marijuana has chemicals, called cannabinoids, that have shown promise in helping ease breast cancer treatment side effects such as nausea, vomiting, and pain.
On this page
- What is medical marijuana?
- How medical marijuana is taken
- How medical marijuana works
- Who gets medical marijuana?
- Insurance coverage for medical marijuana
- Side effects
- Drug interactions with medical marijuana
- Medical marijuana & federal law
- States that allow medical marijuana
- Medical marijuana & the workplace
What is medical marijuana?
Medical marijuana is a phrase used to describe the use of the cannabis plant, either the whole plant or its chemical extracts, to treat symptoms of certain medical conditions or treatment side effects. The marijuana plant contains cannabinoids, unique chemicals that have been found to have medical benefits such as relieving nausea, pain, and loss of appetite that may be side effects of breast cancer treatment.
Delta-9-tetrahydrocannabinol, commonly called THC, is the most-studied cannabinoid compound. But it is also the chemical that produces the intoxicating effect that draws people who use marijuana for recreation. Another cannabinoid, called cannabidiol or CBD, has also shown some health benefits without making you feel intoxicated, or high. Producers have bred marijuana plants that have higher levels of either THC or CBD to achieve certain effects, but there may be added benefits when both are present in the plant.
Scientists have been able to extract or replicate cannabinoids to get a specific effect in a pill or liquid form. Two medicines based on THC, dronabinol (Marinol or Syndros) and nabilone (Cesamet), have been approved by the Food and Drug Administration (FDA) to ease nausea and vomiting caused by cancer chemotherapy.
How medical marijuana is taken
There are several ways to take medical marijuana, including many of the same methods used to take marijuana recreationally. Dronabinol and nabilone, synthetic versions of THC, have been approved by the FDA to treat nausea and vomiting caused by cancer treatments. THC is an active chemical in marijuana that has shown health benefits but also has side effects such as lightheadedness, dizziness, trouble concentrating, and feeling high — effects that are also present in these synthetic pills.
Dronabinol and nabilone are treated the same as other medicines: they can be prescribed by your doctor and may be covered by private insurance and government programs such as Medicare and Medicaid.
- Dronabinol is a synthetic version of THC available as a pill or liquid taken by mouth. It is approved to treat nausea, vomiting and loss of appetite. During a chemotherapy cycle you may take four to six doses in a day for nausea, one every 2 to 4 hours. A first dose is taken an hour or more before getting treatment. For appetite, two doses a day is recommended, one each before lunch and dinner.
- Nabilone is a synthetic version of THC available as a pill taken two to three times a day for nausea during treatment with chemotherapy. A first dose is taken 1 to 3 hours before chemotherapy and it may be continued for 48 hours after chemotherapy.
Federal law still prohibits other ways people take or use medical marijuana, including any methods that burn or heat the dried marijuana plant to inhale smoke or vapor. These methods also are not FDA approved for use in side effect management.
But many states permit people with medical conditions such as breast cancer to buy and use medical marijuana in some or all of these forms:
- Smoking involves burning marijuana in a rolled cigarette, a glass pipe, a water pipe (a pipe in which the smoke is passed through water before being inhaled), certain kinds of vaporizers, or another device and inhaling the smoke.
- Edibles are items containing medical marijuana that can be swallowed or put under the tongue. Edibles deliver medical marijuana’s effects when eaten. Well-known examples of edible marijuana products include baked goods and gummies or chews, but many others have become available in recent years including drinks, lozenges, oils, tinctures, and powders that can be used in a range of food and drink products.
- Vaporizers and e-cigarettes heat an oil extract without burning it. The result is a vapor that can be inhaled.
- Topical creams or gels can be applied to the skin.
- Patches deliver medical marijuana through the skin.
Each method comes with its own pros and cons:
- With a cigarette or pipe, much of the smoke dissipates when you are not inhaling it. Smoking can also be hard for people with lung problems. When marijuana is smoked, you feel its effects very quickly.
- Vaporizers and e-cigarettes come with the same benefits as smoking and may be more convenient. Some evidence suggests vaping may affect the lungs less than smoking, but there is limited information on the safety of many ingredients in vaping oils.
- Edibles and pills can be difficult to take when you are experiencing nausea. They can also take longer to go into effect. Edibles may be easier on your lungs, allow you to control the dose more carefully, and can be used more privately than smoking.
As many states permit medical and recreational use of marijuana, many new marijuana products have become available, especially in edible form. Ask your healthcare team about safe products that can suit your needs.
Remember that each state approves marijuana use differently. They control which health conditions qualify for medical marijuana in your state, in what forms you can buy it, and how you get approved to use it. Cancer is among the conditions permitted in most states.
Dosing for medical marijuana is less regulated than with most medicines. The right dose can be very different from person to person. The common advice is to start with a small amount or dose at first and then try more if your symptoms or side effects don’t get better, increasing the amount a little at a time. If you are not getting relief, ask your doctor about other ways to take medical marijuana or marijuana with different levels of THC and CBD.
No matter what you choose, you should always speak with your healthcare team about any new activity or substance that may affect your treatment.
How medical marijuana works
The body makes chemicals similar to those found in marijuana. These chemicals made in your body are called endocannabinoids, and there are two types of special receptors for them in the brain and throughout the body.
THC and CBD, different cannabinoids found in various forms of medical marijuana, can bind to these receptors and ease some of the side effects associated with breast cancer treatment. Both THC and CBD bind to both types of receptors. THC binds more strongly to a type of receptor found mainly in the brain, and in lesser amounts in other areas of the body. CBD binds to another group of receptors found mainly in parts of the body that have immune function including certain blood cells, the spleen, and the tonsils.
When cannabinoids such as THC or CBD bind to these receptors, they can ease treatment side effects such as nausea and vomiting.
Who gets medical marijuana?
Medical marijuana may be available for people who are having an especially difficult time with treatment side effects that don’t get better with other medicines or management techniques.
Because of the impact marijuana has on human behavior, it has been illegal in the United States since the early 20th century. But individual states have recently started changing their laws to allow people with conditions such as breast cancer to use marijuana for medical purposes.
The National Conference of State Legislatures keeps a list of which states allow medical marijuana use. Even if your state is on the list, there are likely additional steps you must take to use it legally, such as having a doctor certify your condition and registering with the state. Each state has its own rules about what medical marijuana products are allowed and the steps you must take to get and use it legally. For more information, see States that allow medical marijuana below.
Insurance coverage for medical marijuana
Neither government health programs, such as Medicaid and Medicare, nor private health insurance cover medical marijuana. Two FDA-approved medicines based on THC, dronabinol and nabilone, however, may be covered by insurance plans.
Side effects
Like any medicine, medical marijuana can come with some side effects, including:
- Rapid heartbeat
- Low blood pressure
- Bloodshot eyes
- Muscle relaxation
- Slowed digestion
- Dizziness
- Depression
- Paranoia
- Hallucinations
Smoked marijuana may have some of the same effects on the lungs as smoking tobacco. Stopping marijuana use may cause sleeplessness, irritability and hot flashes. Marijuana is less addictive than many prescription medicines and has a much lower risk of overdose.
Drug interactions with medical marijuana
The federal ban on medical marijuana has made it a challenge to study its effects and potential interactions with other medicines. Research observing the effects of cannabinoids on enzymes and processes in the body suggest that it could interfere with many different medicines, including trastuzumab (Herceptin and biosimilars) for breast cancer. At least one study has found an association between cannabis use and shorter survival in people taking immunotherapy for other cancers, though that study also had significant limitations.
It’s important to speak to your doctor about any potential interactions with treatment before starting medical marijuana. Your doctor should also be aware of any other prescriptions, over-the-counter medicines, supplements, or herbs you are taking to be able to assess possible risks. Prescription labels for synthetic THC-based medicines dronabinol and nabilone include several medicines that are of particular importance to mention including antidepressants, antihistamines, different forms of pain medicine, and sleeping pills, among others.
Medical marijuana & federal law
Many states have changed their laws to allow people to use marijuana for certain medical conditions or treatment side effects. But the federal government still considers marijuana a Schedule 1 substance. This category is used to strictly control substances considered to have a high risk for abuse and no currently accepted medical use. This category puts strong restrictions on who can legally grow, buy, or use marijuana whether for recreation, treatment, or research. These federal restrictions conflict with the laws of individual states. This disagreement between state and federal law can make it difficult to know what is allowed.
The federal government has not enforced its restrictions against people who obey their state’s laws but does restrict researchers seeking to learn more about its possible uses in breast cancer treatment. There is much to learn about the effects of medical marijuana and how it can be used to help people with medical conditions, but the Schedule 1 classification makes research more difficult. The status comes with strict rules for using marijuana in a study and makes it harder to get the funding needed to hold clinical trials.
If you are considering medical marijuana to help ease breast cancer treatment side effects, check your state’s laws about its use and speak with your doctor about if it would be right for you.
The difference between state and federal policy on marijuana makes it hard to predict the future of any medical marijuana program. Aside from dronabinol and nabilone, which are approved by the FDA, doctors cannot prescribe medical marijuana because of federal law. Because of this, they can only tell you their opinion on whether it might work for you — but they can’t tell you to take it. It’s also possible that your doctors may not bring up medical marijuana, so you may have to start the conversation if you’re interested.
Because doctors can’t give you a prescription for medical marijuana as they would with other medicines, many states require instead that a doctor certify that you have a condition that qualifies for medical marijuana use. How they certify depends on the state. Your state may require a written letter from your doctor or that they fill out an online form. In some states, the doctor must also register in order to issue medical marijuana eligibility. If your doctor is not registered, they may be able to refer you to someone who is.
States that allow medical marijuana
The National Conference of State Legislatures tracks which states have passed laws to permit the use of medical marijuana. As of April 2023, 38 states as well as Washington, D.C. have programs allowing for the regulated use of medical marijuana products. Some states, such as Colorado and Washington, have legalized marijuana even for recreational use. But in other states, there may be strict regulations on how you get medical marijuana and in what forms it is permitted.
An additional nine states have loosened their laws somewhat. Some allow medical marijuana that is bred to have lower amounts of THC, usually with higher amounts of CBD. Though CBD has been shown effective in treating some conditions, such as seizures, it may not be as effective at treating breast cancer treatment side effects. Other states allow people arrested for marijuana use to claim medical need as a defense in court, but do not have a system to allow you to use marijuana legally.
Source: NCSL.org
States with programs allowing regulated use of medical marijuana (as of April 2023) include Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Hawaii, Illinois, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Dakota, Oklahoma, Ohio, Oregon, Pennsylvania, Rhode Island, South Dakota, Utah, Vermont, Virginia, Washington (state), and West Virginia.
States that allow people arrested for marijuana use to claim medical need as a defense in court, but do not have a system to allow legal use of marijuana (as of April 2023) include Georgia, Indiana, Iowa, North Carolina, South Carolina, Tennessee, Texas, Wisconsin, and Wyoming.
No matter what, obey all local laws and do not travel with medical marijuana to avoid carrying it into a state or locality that bans it.
Medical marijuana & the workplace
You can be legally comfortable using medical marijuana so long as you obey the rules of your state and you are listening to the advice of your doctor. But be aware that there are some other impacts outside the law, such as your workplace. If you are working, check your employer’s policy on medical marijuana use. Several states protect employees taking medical marijuana, so you may be able to request a reasonable accommodation in those places. Reasonable accommodations are changes made in your job, workplace, or schedule to help you work more comfortably while living with a medical condition or its side effects. These are supported by the Americans With Disabilities Act, or ADA.
In most states it is up to your employer to determine their policy on marijuana use. Some types of jobs may not allow its use at all. For example, you may not be protected if you work for the federal government, or if there is a safety concern, such as jobs that require driving or operating heavy machinery.
Stay connected
Sign up to receive emotional support, medical insight, personal stories, and more, delivered to your inbox weekly.
- 3-dimensional radiation therapy
- 4-hydroxytamoxifen
- ablation
- abnormal
- Abraxane
- absolute risk
- AC regimen
- AC-T regimen
- AC-T-T regimen
- AC-Taxol regimen
- AC-TH regimen
- accelerated partial-breast irradiation
- action study
- acupoint
- acupressure
- acupuncture
- acupuncture needle
- acupuncture point
- acupuncture point injection
- acupuncturist
- acustimulation
- acute
- acute pain
- adenocarcinoma
- adenopathy
- adenosis
- adjunct agent
- adjunct therapy
- adjunctive therapy
- adjuvant therapy
- advance directive
- advanced practice nurse
- adverse effect
- aerobic exercise
- agent study
- aggravating factor
- aggressive
- AJCC staging system
- Alkeran
- alkylating agent
- Allegra
- allopathic medicine
- alopecia
- amifostine
- aminoglutethimide
- amitriptyline
- anabolic steroid
- analgesic
- anaplastic
- anastrozole
- ancillary test
- anemia
- anesthesia
- anesthesiologist
- angiogenesis
- angiogenesis inhibitor
- antagonist
- anthracycline
- anti-anxiety medicine
- anti-idiotype vaccine
- anti-inflammatory
- antibody-dependent cellular cytotoxicity
- antibody therapy
- anticachexia
- anticancer antibiotic
- anticancer therapy
- anticonvulsant
- antidepressant
- antiemetic
- antiestrogen
- antifolate
- antigen-presenting cell vaccine
- antihormone therapy
- antimetabolite
- antimitotic agent
- antineoplastic
- antitumor
- anxiety
- anxiolytic
- Anzemet
- APN
- apocrine gland
- apoptosis
- aprepitant
- areola
- Aromasin
- aromatase inhibitor
- aromatherapy
- arthralgia
- ascites
- aspirate
- aspiration
- assay
- asthenia
- asymptomatic
- atypia
- atypical ductal hyperplasia
- atypical hyperplasia
- atypical lobular hyperplasia
- avoidance
- axillary lymph node
- axillary lymph node dissection
- BAK gel
- balloon catheter radiation
- baseline
- behavior modification
- best practice
- BI-RADS
- Biafine cream
- bias
- bilateral
- bilateral breast cancer
- bilateral prophylactic mastectomy
- bilateral salpingo-oophorectomy
- biofeedback
- biologic
- biopsy
- biopsy specimen
- biotherapy
- bisphosphonate
- bisphosphonate-associated osteonecrosis
- blinded study
- blood-brain barrier
- blood-brain barrier disruption
- blood cell count
- blood chemistry study
- board certified oncology pharmacy specialist
- body image
- body mass index
- bolus dose
- bone density
- bone metastasis
- bone mineral density scan
- bone scan
- bone-seeking radioisotope
- brachytherapy
- brain metastasis
- BRCA1
- BRCA2
- BRCAPro
- breast carcinoma in situ
- breast-conserving surgery
- breast density
- breast duct
- breast duct endoscopy
- breast lobe
- breast lobule
- breast reconstruction
- breast self-exam
- Brief Pain Inventory
- cachexia
- CAF regimen
- calcification
- cancer vaccine
- candidiasis
- capecitabine
- carboplatin
- carcinogen
- carcinoma
- carcinoma in situ
- carcinomatous meningitis
- carcinosis
- carcinostatic
- cardiotoxicity
- caregiver
- carmustine
- case-control study
- case report
- case series
- CAT scan
- CBC
- cell
- cell-cycle regulation
- cell proliferation
- central nervous system
- central nervous system metastasis
- central nervous system prophylaxis
- central venous access catheter
- cetuximab
- cevimeline
- chaplain
- charged-particle radiation therapy
- chemoembolization
- chemoimmunotherapy
- chemoprevention
- chemoprevention study
- chemoprotective
- chemoradiation
- chemosensitivity
- chemosensitivity assay
- chemosensitizer
- chemotherapeutic agent
- chemotherapy
- chest wall
- chest X-ray
- Chinese meridian theory
- chronic
- chronic pain
- cisplatin
- Claus model
- clergy
- clinical
- clinical breast exam
- clinical practice guidelines
- clinical researcher
- clinical resistance
- clinical series
- clinical stage
- clinical staging
- clinical study
- clinical trial
- clinician
- clodronate
- CMF regimen
- cognition
- cognitive behavior therapy
- cognitive therapy
- cohort
- cohort study
- combination chemotherapy
- comedo carcinoma
- comfort care
- Coming Out
- Community Advisory Board
- comorbidity
- compassionate use trial
- complementary and alternative medicine
- complementary medicine
- complete metastasectomy
- complete remission
- complete response
- complex decongestive therapy
- compliance
- complication
- compression garment
- computed tomography scan
- concomitant
- concurrent therapy
- condition
- consolidation therapy
- constitutional acupuncture
- continuum of care
- contract research organization
- contraindication
- contralateral
- contrast material
- control group
- controlled clinical trial
- controlled study
- conventional medicine
- conventional therapy
- cope
- coping skills
- core biopsy
- core needle biopsy
- corticosteroid
- counseling
- COX inhibitor
- cryoablation
- cryopreservation
- cryosurgery
- CT scan
- cultural competency
- cumulative dose
- cumulative exposure
- cure
- cutaneous
- cutaneous breast cancer
- cyclophosphamide
- cyclosporine
- CYP2D6 inhibitor
- cystosarcoma phyllodes
- cytopenia
- cytotoxic
- cytotoxic chemotherapy
- Cytoxan
- Data and Safety Monitoring Board
- DCIS
- de novo
- debulking
- definitive surgery
- definitive treatment
- dehydration
- denosumab
- depression
- diagnosis
- diagnostic mammogram
- diagnostic procedure
- diagnostic technique
- diagnostic trial
- diameter
- diarrhea
- diaziquone
- DIEP flap
- dietary counseling
- dietary supplement
- dietitian
- differentiation
- diffuse
- digital mammography
- diphenhydramine
- discharge
- disease progression
- disease-specific survival rate
- distant cancer
- distant metastasis
- Distant recurrence
- distress
- DNR order
- docetaxel
- dolasetron
- dose
- dose-dense chemotherapy
- dose-dependent
- dose-limiting
- dose-rate
- double-blinded
- doxorubicin
- drain
- dronabinol
- droperidol
- drug interaction
- drug resistance
- drug therapy
- drug tolerance
- duct
- ductal carcinoma
- ductal carcinoma in situ
- ductal lavage
- duloxetine
- durable power of attorney
- dysfunction
- dysgeusia
- dyspepsia
- dyspnea
- early menopause
- early-stage breast cancer
- edema
- EEG biofeedback
- efficacy
- Eklund displacement views
- electroacupuncture
- electron beam
- eligibility criteria
- Ellence
- emesis
- emetic
- endocrine
- endocrine therapy
- endpoint
- energy healing
- enteral nutrition
- epidemiology
- epirubicin
- ER+
- ER-
- ER
- ER-PR-HER2/neu-
- eribulin mesylate
- erythema
- estradiol
- estrogen
- estrogen blocker
- estrogen receptor
- estrogen receptor-negative
- estrogen receptor-positive
- estrogen receptor test
- estrogen replacement therapy
- etanidazole
- etidronate
- everolimus
- Evista
- excision
- excisional biopsy
- exemestane
- expanded access trial
- experimental
- extranodal
- false-negative test result
- false-positive test result
- familial cancer
- family medical history
- Faslodex
- fast-neutron beam radiation
- fatigue
- FDA
- febrile neutropenia
- FEC regimen
- Femara
- fertility
- fexofenadine
- fibroadenoma
- fibrocystic breast changes
- fiducial marker
- film mammography
- fine-needle aspiration biopsy
- first-degree relative
- first-line therapy
- five-year survival rate
- fluorouracil
- fluoxetine
- FNA biopsy
- focal
- Food and Drug Administration
- Fosamax
- fractionation
- fulvestrant
- functional magnetic resonance imaging
- gadolinium
- Gail model
- gallium scan
- gamma irradiation
- Gamma Knife therapy
- gamma ray
- Gelclair
- gemcitabine
- gene
- gene expression profile
- gene therapy
- general anesthesia
- generalized anxiety disorder
- generic
- genetic
- genetic counseling
- genetic marker
- genetic marker of susceptibility
- genetic predisposition
- genetic profile
- genetic susceptibility
- genetic testing
- genetic testing
- genetics
- genome
- genome-wide association study
- genomic profile
- genomic test
- genomics
- gland
- Good Clinical Practice
- goserelin
- grade
- grading
- granisetron
- gross description
- Halaven
- hazard ratio
- healing touch
- Health Insurance Portability and Accountability Act
- healthcare provider
- healthcare proxy
- healthy control
- helical computed tomography
- HER2/neu
- Herceptin
- hereditary
- hereditary mutation
- heteronormative
- high-dose chemotherapy
- high-dose radiation
- high-energy proton therapy
- high grade
- high-risk cancer
- HIPPA
- histologic examination
- histology
- historic cohort study
- historical control subject
- homeopathic medicine
- hormonal therapy
- hormone
- hormone receptor
- hormone receptor test
- hormone replacement therapy
- hormone responsive
- hormone therapy
- hospice
- hot flash
- human epidermal growth factor receptor 2
- human participant protection regulations
- hydroxydaunorubicin
- hyperalimentation
- hypercalcemia
- hyperfractionated radiation therapy
- hyperfractionation
- hyperplasia
- hypersensitivity
- hypofractionated radiation therapy
- hypofractionation
- hypoxia
- ibandronate
- ibuprofen
- idiopathic
- image-guided radiation therapy
- imaging
- imaging procedure
- immune adjuvant
- immune function
- immune response
- immune system
- immune system tolerance
- immunization
- immunoassay
- immunocompromised
- immunodeficiency
- immunohistochemistry
- immunology
- immunomodulation
- immunosuppression
- immunotherapy
- implant
- implant displacement views
- implant radiation therapy
- implantable pump
- in situ
- incidence
- incision
- incisional biopsy
- indication
- indolent
- induction therapy
- infection
- infertile
- infertility
- infiltrating breast cancer
- infiltrating ductal carcinoma
- inflammation
- inflammatory breast cancer
- informed consent
- infusion
- ingestion
- inherited
- iniparib
- injection
- inoperable
- insomnia
- Institutional Review Board
- intensification therapy
- intensity-modulated radiation therapy
- interfering thought
- internal mammary lymph nodes
- internal radiation therapy
- International Unit
- internist
- interstitial radiation therapy
- intervention
- intervention group
- intra-arterial
- intracarotid infusion
- intradermal
- intraductal breast papilloma
- intraductal carcinoma
- intrahepatic
- intrahepatic infusion
- intramuscular
- intramuscular injection
- intraoperative radiation therapy
- intraoperative ultrasound
- intratumoral
- intravasation
- intravenous
- intravenous infusion
- intravenous injection
- intrusive thought
- intrusive thoughts
- invasive breast cancer
- invasive cancer
- invasive procedure
- investigational
- investigator
- ionizing radiation
- ipsilateral
- IRB
- irradiated
- irradiation
- irreversible toxicity
- ixabepilone
- joint pain
- Karnofsky Performance Status
- laboratory test
- lapatinib
- laser
- laser surgery
- laser therapy
- lassitude
- late effects
- late-stage cancer
- latent
- laxative
- LEEP
- legal aid organization
- lesion
- lethargy
- letrozole
- leukopenia
- levels of evidence
- Lexapro
- libido
- lidocaine
- ligation
- linac
- linear accelerator
- lipoma
- lisofylline
- liver metastasis
- liver scan
- living will
- lobaplatin
- lobe
- lobectomy
- lobular carcinoma
- lobular carcinoma in situ
- lobule
- local anesthesia
- local cancer
- local therapy
- localization
- localized
- locally advanced cancer
- locally recurrent cancer
- lomustine
- loop electrosurgical excision procedure
- loop excision
- lorazepam
- low grade
- lubricant
- lumbar puncture
- lumpectomy
- lung metastasis
- luteinizing hormone-releasing hormone agonist
- lymph
- lymph gland
- lymph node
- lymph node dissection
- lymph node drainage
- lymph node mapping
- lymph vessel
- lymphadenectomy
- lymphadenopathy
- lymphangiogram
- lymphangiography
- lymphatic basin
- lymphatic fluid
- lymphatic mapping
- lymphatic system
- lymphatic vessel
- lymphedema
- lymphography
- lymphoscintigraphy
- Lyrica
- lytic lesion
- macrocalcification
- magnetic resonance imaging
- magnetic resonance perfusion imaging
- magnetic resonance spectroscopic imaging
- mainstream medicine
- maintenance therapy
- male breast cancer
- malignancy
- malignant
- malignant pleural effusion
- malnutrition
- mammary
- mammary dysplasia
- mammary gland
- mammogram
- mammography
- MammoSite
- Mammotome
- mantle field
- MAO inhibitor
- margin
- marker
- mass
- massage therapy
- mastectomy
- mastitis
- maternal
- maximum tolerated dose
- mean survival time
- measurable disease
- medial supraclavicular lymph node
- median
- median survival time
- Medicaid
- medical castration
- medical device
- medical nutrition therapy
- medical oncologist
- Medicare
- medicine
- medullary breast carcinoma
- mega-voltage linear accelerator
- megestrol
- melphalan
- meningeal metastasis
- menopause
- menorrhagia
- menstrual cycle
- menstrual period
- menstruation
- mental health
- mental health counselor
- meridian
- mesna
- meta-analysis
- metallic
- metastasectomy
- metastasis
- metastasize
- metastatic
- methotrexate
- metoclopramide
- metronomic therapy
- microcalcification
- micrometastasis
- microscopic
- milk duct
- mind/body exercise
- mindfulness relaxation
- Miraluma test
- mitigate
- modified radical mastectomy
- molecular marker
- molecular medicine
- molecular risk assessment
- molecularly targeted therapy
- monoamine oxidase inhibitor
- monoclonal antibody
- morbidity
- mortality
- MRI
- MRSI
- MTD
- mTOR
- mucositis
- multicenter study
- multicentric breast cancer
- multidisciplinary
- multidisciplinary opinion
- multidrug resistance
- multidrug resistance inhibition
- multifocal breast cancer
- music therapy
- mutation
- mutation carrier
- myalgia
- myelosuppression
- nanoparticle paclitaxel
- narcotic
- National Cancer Institute
- National Center for Complementary and Alternative Medicine
- National Institutes of Health
- natural history study
- naturopathy
- nausea
- NCCAM
- NCI
- NCI clinical trials cooperative group
- needle biopsy
- needle localization
- needle-localized biopsy
- negative axillary lymph node
- negative test result
- neoadjuvant therapy
- neoplasm
- nerve
- nerve block
- neurocognitive
- neurologic
- neuropathy
- neurotoxicity
- neurotoxin
- neutropenia
- NIH
- nipple
- nipple discharge
- nitrosourea
- NMRI
- node-negative
- node-positive
- nodule
- nonblinded
- nonconsecutive case series
- noninvasive
- nonmalignant
- nonmetastatic
- nonprescription
- nonrandomized clinical trial
- nonsteroidal anti-inflammatory drug
- nonsteroidal aromatase inhibitor
- nontoxic
- normal range
- normative
- NP
- NPO
- NSAID
- nuclear grade
- nuclear magnetic resonance imaging
- nuclear medicine scan
- nurse
- nurse practitioner
- nutrition
- nutrition therapy
- nutritional counseling
- nutritional status
- nutritional supplement
- nutritionist
- obese
- objective improvement
- objective response
- observation
- observational study
- obstruction
- off-label
- olaparib
- oncologist
- oncology
- oncology nurse
- oncology pharmacy specialist
- oncolysis
- ondansetron
- onset of action
- oophorectomy
- open biopsy
- open label study
- open resection
- operable
- opiate
- opioid
- opportunistic infection
- oral
- organ
- orthodox medicine
- osteolytic
- osteonecrosis of the jaw
- osteopenia
- osteoporosis
- OTC
- outcome
- outpatient
- ovarian
- ovarian ablation
- ovarian cancer
- ovarian suppression
- ovary
- over-the-counter
- overall survival rate
- overdose
- overexpress
- overweight
- ovulation
- PA
- paclitaxel
- paclitaxel albumin-stabilized nanoparticle formulation
- paclitaxel-loaded polymeric micelle
- Paget disease of the nipple
- pain threshold
- palliation
- palliative care
- palliative therapy
- palmar-plantar erythrodysesthesia
- palonosetron hydrochloride
- palpable disease
- palpation
- palpitation
- pamidronate
- panic
- papillary tumor
- Paraplatin
- parenteral nutrition
- paroxetine hydrochloride
- PARP
- PARP inhibitor
- partial-breast irradiation
- partial mastectomy
- partial oophorectomy
- partial remission or partial response
- pastoral counselor
- paternal
- pathologic fracture
- pathological stage
- pathological staging
- pathologist
- pathology report
- patient advocate
- Paxil
- peau d'orange
- pedigree
- peer-review process
- peer-reviewed scientific journal
- perfusion magnetic resonance imaging
- perimenopausal
- periodic neutropenia
- perioperative
- peripheral neuropathy
- peripheral venous catheter
- personal health record
- personal medical history
- personalized medicine
- Pertuzumab
- PET scan
- pharmacist
- phase I/II trial
- phase I trial
- phase II/III trial
- phase II trial
- phase III trial
- phase IV trial
- phlebotomy
- photon beam radiation therapy
- phyllodes tumor
- physical examination
- physical therapist
- physical therapy
- physician
- physician assistant
- physiologic
- PI3 kinase inhibitor
- pilocarpine
- pilot study
- placebo
- placebo-controlled
- plastic surgeon
- plastic surgery
- population study
- positive axillary lymph node
- positive test result
- positron emission tomography scan
- post-traumatic stress disorder
- postmenopausal
- postoperative
- postremission therapy
- potentiation
- power of attorney
- PR
- PR+
- PR-
- practitioner
- precancerous
- preclinical study
- predictive factor
- pregabalin
- premalignant
- premature menopause
- premenopausal
- prescription
- prevention
- preventive
- preventive mastectomy
- primary care
- primary care doctor
- primary endpoint
- primary therapy
- primary treatment
- primary tumor
- Principal investigator
- prochlorperazine
- progesterone
- progesterone receptor
- progesterone receptor-negative
- progesterone receptor-positive
- progesterone receptor test
- progestin
- prognosis
- prognostic factor
- progression
- progression-free survival
- progressive disease
- Prolia
- proliferative index
- promegapoietin
- prophylactic
- prophylactic mastectomy
- prophylactic oophorectomy
- prophylactic surgery
- prophylaxis
- prospective
- prospective cohort study
- prosthesis
- protective factor
- protein
- protein-bound paclitaxel
- protein expression
- protein expression profile
- protocol
- proton
- proton magnetic resonance spectroscopic imaging
- pruritus
- psychiatrist
- psychological
- psychologist
- psychosocial
- psychotherapy
- PTSD
- pump
- punch biopsy
- qi
- qigong
- quadrantectomy
- quality assurance
- quality of life
- radiation
- radiation brachytherapy
- radiation dermatitis
- radiation fibrosis
- radiation necrosis
- radiation nurse
- radiation oncologist
- radiation physicist
- radiation surgery
- radiation therapist
- radiation therapy
- radical lymph node dissection
- radical mastectomy
- radioactive
- radioactive drug
- radioactive seed
- radioisotope
- radiologic exam
- radiologist
- radiology
- radionuclide
- radionuclide scanning
- radiopharmaceutical
- radiosensitization
- radiosensitizer
- radiosurgery
- radiotherapy
- raloxifene
- raloxifene hydrochloride
- randomization
- randomized clinical trial
- receptor
- RECIST
- reconstructive surgeon
- reconstructive surgery
- recreational therapy
- recurrence
- recurrent cancer
- referral
- reflexology
- refractory
- refractory cancer
- regimen
- regional
- regional anesthesia
- regional cancer
- regional chemotherapy
- regional lymph node
- regional lymph node dissection
- registered dietician
- regression
- rehabilitation
- rehabilitation specialist
- relapse
- relative survival rate
- relaxation technique
- remission
- remission induction therapy
- remote brachytherapy
- research nurse
- research study
- resectable
- resected
- resection
- residual disease
- resistant cancer
- resorption
- respite care
- response rate
- retrospective cohort study
- retrospective study
- risk factor
- Rubex
- salpingo-oophorectomy
- salvage therapy
- samarium 153
- sargramostim
- scalpel
- scan
- scanner
- scintigraphy
- scintimammography
- sclerosing adenosis
- screening
- screening mammogram
- second-line therapy
- second-look surgery
- second primary cancer
- secondary cancer
- secrete
- sedative
- segmental mastectomy
- selection bias
- selective estrogen receptor modulator
- selective serotonin reuptake inhibitor
- sentinel lymph node
- sentinel lymph node biopsy
- sentinel lymph node mapping
- sepsis
- sequential AC/Taxol-Trastuzumab regimen
- sequential treatment
- SERM
- sertraline
- Serzone
- sestamibi breast imaging
- sexuality
- sibling